Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Rashad Al Salahi"'
Publikováno v:
Separations, Vol 10, Iss 9, p 494 (2023)
Entrectinib is an oral selective inhibitor of the neurotrophic T receptor kinase (NTRK). It is used in the treatment of solid tumors in NTRK gene fusion lung cancer. The study aimed to develop and validate an analytical method for quantifying entrect
Externí odkaz:
https://doaj.org/article/57430bcef09b4e1ba5ecb0ee1844e3cb
Autor:
Hatem A. Abuelizz, Hanan A. A. Taie, Ahmed H. Bakheit, Gamal A. E. Mostafa, Mohamed Marzouk, Harunor Rashid, Rashad Al-Salahi
Publikováno v:
ACS Omega, Vol 6, Iss 47, Pp 31993-32004 (2021)
Externí odkaz:
https://doaj.org/article/06009aa7dc514ee39ea6677aaa673635
Autor:
Hatem A. Abuelizz, Nor Azman N. I. Iwana, Rohaya Ahmad, El-Hassane Anouar, Mohamed Marzouk, Rashad Al-Salahi
Publikováno v:
BMC Chemistry, Vol 13, Iss 1, Pp 1-14 (2019)
Abstract Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial gluco
Externí odkaz:
https://doaj.org/article/637eca829d9b45768e8a6d4a7065afc0
Autor:
Abdullah M. Al-Hossaini, Hany W. Darwish, Ahmed Y. Sayed, Nasr Y. Khalil, Rashad Al-Salahi, Ibrahim A. Darwish
Publikováno v:
Applied Sciences, Vol 12, Iss 20, p 10460 (2022)
Duvelisib (DUV) is a novel drug with a small molecular weight and characterized by dual phosphoinositide-3-kinase (PI3K)- and PI3K-inhibitory activity. The Food and Drug Administration (FDA) recently approved DUV for the management of small lymphocyt
Externí odkaz:
https://doaj.org/article/62adad46a43949da9c395710850e7e2a
Autor:
Haya I. Aljohar, Abdulmajeed A. Alghamdi, Nasr Y. Khalil, Hany W. Darwish, Rashad Al-Salahi, Ibrahim A. Darwish
Publikováno v:
Applied Sciences, Vol 12, Iss 20, p 10624 (2022)
The Food and Drug Administration (FDA) has approved duvelisib (DUV) for managing follicular lymphoma, small lymphocytic lymphoma, and relapsed or refractory chronic lymphocytic leukemia. Seliciclib (SEL) is a candidate drug for these cancers, neurode
Externí odkaz:
https://doaj.org/article/99d018f12df14f11af8d8cde1c9639fe
Publikováno v:
Molecules, Vol 27, Iss 19, p 6320 (2022)
This study describes the non-covalent interactions of the charge transfer complex (CT), which was responsible for the synthesis of Linagliptin (LNG) with 2,3-Dichloro-5,6-Dicyano-1,4-benzoquinone (DDQ), or with Chloranilic acid (CHA) complexes in ace
Externí odkaz:
https://doaj.org/article/c7f00fc69fb04456905061d2933c4765
Autor:
Hatem A. Abuelizz, Ahmed H. Bakheit, Mohamed H. Al-Agamy, Harunor Rashid, Gamal A.E. Mostafa, Rashad Al-Salahi
Publikováno v:
Saudi Pharmaceutical Journal. 31:815-823
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ea8a87db25192d4410d4b76e228b0aa
https://doi.org/10.1016/j.jsps.2023.04.012
https://doi.org/10.1016/j.jsps.2023.04.012
Publikováno v:
Applied Sciences, Vol 12, Iss 12, p 5998 (2022)
5-Aminoisoquinoline (5-AIQ) is a water-soluble, potent and selective Poly (ADP-ribose) polymerase 1 (PARP-1) inhibitor, widely used as a biochemical and pharmacological tool to study the inhibitory effect of PARPs enzyme. In this study, a simple, sel
Externí odkaz:
https://doaj.org/article/4279e342cec34b5ba977953cad3552ff
Autor:
Hatem A. Abuelizz, Ahmed H. Bakheit, Mohamed Marzouk, Mohamed M. Abdellatif, Rashad Al-Salahi
Publikováno v:
Molecules, Vol 27, Iss 11, p 3550 (2022)
The cyclic anhydrides are broadly employed in several fields, such as the chemical, plastic, agrochemical, and pharmaceutical industries. This study describes the chemical reactivity of 4,5-dichlorophthalic anhydride towards several nucleophiles, inc
Externí odkaz:
https://doaj.org/article/fa2b43fd0447465297c68296d072fe02
Autor:
Hatem A. Abuelizz, Ahmed H. Bakheit, Mohamed Marzouk, Waled M. El-Senousy, Mohamed M. Abdellatif, Gamal A. E. Mostafa, Rashad Al-Salahi
Publikováno v:
Current Issues in Molecular Biology; Volume 45; Issue 3; Pages: 2409-2421
Globally, rotavirus (RV) is the most common cause of acute gastroenteritis in infants and toddlers; however, there are currently no agents available that are tailored to treat rotavirus infection in particular. Improved and widespread immunization pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60bd9bf051fa61d877932e9ea0c3ef45
https://doi.org/10.3390/cimb45030156
https://doi.org/10.3390/cimb45030156